HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Ratner Selected Research

N Ratner Research Topics

Disease

9Neoplasms (Cancer)
12/2014 - 05/2000
5Neurofibrosarcoma (MPNST)
12/2014 - 05/2000
5Neurofibromatosis 1 (Neurofibromatosis Type I)
12/2014 - 05/2000
4Neurofibroma
01/2017 - 05/2000
3Neurofibromatosis 2 (Neurofibromatosis Type II)
02/2013 - 11/2000
2Neurilemmoma (Schwannoma)
02/2013 - 01/2001
1Plexiform Neurofibroma
01/2017
1Ependymoma
02/2013
1Meningioma (Meningiomas)
02/2013
1Necrosis
01/2010
1Sarcoma (Soft Tissue Sarcoma)
01/2010
1Neoplasm Metastasis (Metastasis)
07/2001
1Nervous System Neoplasms (Neoplasms, Nervous System)
01/2001
1Papilloma (Papillomatosis)
06/2000
1Skin Neoplasms (Skin Cancer)
06/2000
1Neurofibromatoses (Neurofibromatosis)
05/2000
1Carcinogenesis
05/2000

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
02/2013 - 09/2000
4Neurofibromin 2 (Merlin)IBA
02/2013 - 11/2000
2Small Interfering RNA (siRNA)IBA
01/2014 - 01/2010
2ErbB Receptors (EGF Receptor)IBA
01/2014 - 05/2000
2Guanosine Triphosphate (GTP)IBA
09/2000 - 06/2000
2Neurofibromin 1 (Neurofibromin)IBA
09/2000 - 06/2000
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017
1Transcription Factors (Transcription Factor)IBA
12/2014
1Differentiation AntigensIBA
12/2014
1EverolimusFDA Link
12/2014
1FLLL 32IBA
01/2014
1GTP Phosphohydrolases (GTPases)IBA
02/2013
1p38 Mitogen-Activated Protein KinasesIBA
02/2013
11,2-cyclohexanediamine (dach)IBA
01/2010
1Messenger RNA (mRNA)IBA
01/2010
1Antimitotic AgentsIBA
02/2001
1Cyclin D1IBA
02/2001
1MitogensIBA
01/2001
1AgarIBA
01/2001
1MidkineIBA
01/2001
1pleiotrophin (HARP)IBA
01/2001
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2001
1ezrinIBA
11/2000
1radixinIBA
11/2000
1moesinIBA
11/2000
1ras ProteinsIBA
09/2000
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
06/2000
1anthraceneIBA
06/2000
1CarcinogensIBA
06/2000
1Codon (Codons)IBA
06/2000
1Epidermal Growth Factor (EGF)IBA
05/2000

Therapy/Procedure

3Therapeutics
12/2014 - 01/2010
1Transplantation
01/2017
1Aftercare (After-Treatment)
06/2000